Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: First In Human Study (EMBARK Study)

NCT05182307 is registered in ClinicalTrials.gov with Anteris Technologies Ltd. as lead sponsor.

NCT NCT05182307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05182307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: First In Human Study (EMBARK Study)
Lead sponsor
Anteris Technologies Ltd.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 15, 2021
Completion date
April 30, 2028
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve calcification, severe aortic valve stenosis, symptomatic aortic stenosis